Sign in
4

Changes in Ownership

SCYNEXIS INC Filed Acc 0001209191-19-011123

Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Angulo Gonzalez David Chief Medical Officer 2019-02-15 Grant or award +150,000 271,790 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Angulo Gonzalez David Chief Medical Officer 2019-02-15 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…